HD-OPM Archive
Topics › Lp(a)

Statins remain essential for high Lp(a) even though they raise Lp(a) 5-20%

Louis Nervegna · Apr 06, 2025 · ♥ 8 reactions · 9 comments · original Facebook post
Lp(a)Statins
AI summary & key facts

Louis shares a video of Stanford's Joshua Knowles explaining why the small statin-related rise in Lp(a), shown in meta-analyses of RCTs, does not matter clinically and why statins are an important treatment for genetically high Lp(a). He cites over 25 long-running statin RCTs, including primary prevention trials, showing large reductions in heart attack and stroke.

Statins are proven to lower risk of heart attacks, strokes, and cardiovascular mortality in people with high Lp(a).

facebook.com/share/v/1CY8vQdPB2

Research cited

Statins and Lp(a)

Meta-analyses of randomized controlled trials have shown that statins can raise Lp(a) levels by as much as 5-20%.

For example:

Paper · European Heart JournalEuropean Heart Journal articleacademic.oup.com

In this video, Joshua Knowles MD, PhD— a professor of cardiovascular medicine at Stanford University— explains why this does not matter clinically. Knowles is a world-renowned expert on genetic causes of high cholesterol, including high Lp(a). Knowles explains that statins are an important part of the treatment for patients with genetically high Lp(a).

Bio of Joshua Knowles:

CAP ProfilesJoshua W. Knowles | Stanford Medicinemed.stanford.edu

As Knowles alludes to in the video, there are over 25 large long-running randomized controlled trials that have demonstrated that statins lower risk for heart attacks and strokes. This includes people with high Lp(a).

↪ 25 statin RCTs: about 75 mg/dL LDL lowering cut heart attack and stroke roughly 40%

Combining data from all these 25 trials:

Lowering LDL by about 75mg/dL (1.9mmol/L) with a statin reduces the risk of having a heart attack or stroke (MACE) by about 40% on average, as compared to people taking a placebo.

7 of these 25 clinical trials were primary prevention trials— participants who never had a heart attack or stroke before. The risk reductions for the 7 primary prevention trials were even larger than the risk reductions for the 18 secondary prevention trials.

Reference for risk reduction from the 25 statin trials:
↪ 25 statin RCTs: about 75 mg/dL LDL lowering cut heart attack and stroke roughly 40%

#statinslpaHD #statinsHD #lpaHD

← newer: Keto-CTA (LMHR): very high LDL keto dieters with plaque keptolder: Reddit post from Eric Berg's son describing a cult-like work →